UT Health San Antonio | The University of Texas Health Science Center at San Antonio
Briseida “Bee” Courtois, MSW, LCDC, program manager of Be Well Texas, a substance use disorder response program of UT Health San Antonio, was interviewed for this story.   Read More

Josephine Taverna, MD, Medical Oncology, was quoted in this interview.   Read More      

UT Health San Antonio contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu Hill Country MHDD contact: Kelsi Wilmot, 830-370-6302, kelsi8310@hillcountry.org SAN ANTONIO, Dec. 7, 2022 – Be Well Texas, a statewide initiative of UT Health San Antonio, and Hill Country Mental Health & Developmental Disabilities Centers have entered into an agreement to provide substance use disorder (SUD)…

Jessica Solis-McCarthy, MD, Emergency Medicine, was quoted in this news segment.   Read More

Sara Masoud, MPH, a doctoral student in translational science who runs a memory cafe and coordinates a network of cafes as part of her work with the Caring for the Caregiver program, was quoted in this story.   Read More

Roxana Delgado, PhD, MS, a health scientist and epidemiologist with the Department of Medicine, wrote this article.   Read More

Be Well Texas, a statewide initiative of UT Health San Antonio, and Hill Country Mental Health & Developmental Disabilities Centers  entered into an agreement to provide substance use disorder treatment services to Uvalde residents. They will jointly provide on-demand, 24/7 access to a virtual-navigation hub for peer recovery support services, behavioral health screening, case management […]

  Be Well Texas, a statewide initiative of UT Health San Antonio, and Hill Country Mental Health & Developmental Disabilities Centers entered into an agreement to provide substance use disorder treatment services to Uvalde residents. They will jointly provide on-demand, 24/7 access to a virtual-navigation hub for peer recovery support services, behavioral health screening, case […]

The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease.   The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, part of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), […]

Rachel Pearson, MD, PhD, Pediatrics/Center for Medical Humanities and Ethics, is quoted in this story.   Read More